MNMD

Mind Medicine MindMed Stock Price

3.30
-0.11 (-3.23%)
Upgrade to Real-Time
Afterhours (Closed)
3.30

Low
3.05

52 Week Range

High
5.77

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Mind Medicine MindMed Inc MNMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.11 -3.23% 3.30 19:58:36
Open Price Low Price High Price Close Price Prev Close
3.41 3.22 3.44 3.28 3.41
Bid Price Ask Price Spread News
3.26 3.33 0.07 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
22,181 5,662,791 $ 3.31 $ 18,769,012 9,257,467 3.05 - 5.77
Last Trade Time Type Quantity Stock Price Currency
19:59:44 30 $ 3.29 USD

Mind Medicine MindMed Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.08B 326.13M 326.13M $ - $ - -0.06 -39.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Mind Medicine MindMed News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MNMD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.224.253.053.4417,260,681-0.92-21.8%
1 Month5.775.773.053.9226,271,614-2.47-42.81%
3 Months5.775.773.053.9226,271,614-2.47-42.81%
6 Months5.775.773.053.9226,271,614-2.47-42.81%
1 Year5.775.773.053.9226,271,614-2.47-42.81%
3 Years5.775.773.053.9226,271,614-2.47-42.81%
5 Years5.775.773.053.9226,271,614-2.47-42.81%

Mind Medicine MindMed Description

Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.


Your Recent History
NASDAQ
MNMD
Mind Medic..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.